참고문헌 (78)

1. Bach The NOD mouse Res Immunol 1997 148 285 10.1016/s0923-2494(97)87235-5 

   상세보기

2. Atkinson The NOD mouse model of type 1 diabetes: as good as it gets? Nature Med 1999 10.1038/9442 5 601 

   상세보기

3. Rossini Spontaneous diabetes in gnotobiotic BB/W rat Diabetes 1979 10.2337/diab.28.11.1031 28 1031 

   상세보기

4. Like Spontaneous autoimmune diabetes mellitus in the BB rat Diabetes 1982 10.2337/diab.31.1.S7 31 Suppl. 1 7 

   상세보기

5. Knip IDDM prevention trials in progress - a critical assessment J Pediatr Endocrinol Metab 1998 2 371 

6. Sperling Aspects of the etiology, prediction, and prevention of insulin-dependent diabetes mellitus in childhood Pediatr Clin North Am 1997 10.1016/S0031-3955(05)70476-4 44 269 

   상세보기

7. Naik Preservation of β cell function in type 1 diabetes Diabetes Rev 1999 7 154 

8. Tercyak Patient and family reflections on the use of subcutaneous insulin to prevent diabetes: a retrospective evaluation from a pilot prevention trial J Diabetes Complications 1998 12 279 10.1016/s1056-8727(98)00005-1 

   상세보기

9. Rabinovich Prevention of type 1 diabetes Med Clin North Am 1998 10.1016/S0025-7125(05)70022-5 82 739 

   상세보기

10. The Diabetes Control and Complication Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long-term complications in adolescents with insulin-dependent diabetes mellitus. Diabetes Control Complications Trial J Pediatr 1994 125 188 

11. Becker Intensive diabetes therapy in childhood: is it achievable? Is it desirable? Is it safe? J Pediatr 1999 10.1016/S0022-3476(99)70194-0 134 392 

    상세보기

12. Rosenbloom Therapeutic controversy. Prevention and Treatment of Diabetes in Children J Clin Endocrinol Metab 2000 85 494 

13. Akerblom Emergence of diabetes associated autoantibodies in the nutritional prevention of IDDM (TRIGR) project Diabetes 2000 48 Suppl.1 A45 

14. Eisenbarth Type I diabetes mellitus: a chronic autoimmune disease N Engl J Med 1986 10.1056/NEJM198605223142106 314 1360 

    상세보기

15. Theofilopoulos The basis of autoimmunity: Part I. Mechanisms of aberrant self-recognition Immunol Today 1995 10.1016/0167-5699(95)80095-6 16 90 

    상세보기

16. Bellgrau Molecular Mechanisms of Endocrine and Organ Specific Autoimmunity. 1999 1 

17. Rose Handbook of Immunology. 1997 111 

18. Pietropaolo Molecular Biology of Diabetes. 1994 1 

19. Galperin Use of recombinant proteins in the diagnosis of autoimmune connective tissue diseases Int Arch Allergy Immunol 1996 10.1159/000237390 111 337 

    상세보기

20. Grubin A novel radiobinding assay to determine diagnostic accuracy of isoform-specific glutamic acid decarboxylase antibodies in childhood IDDM Diabetologia 1994 10.1007/BF00408469 37 344 

    상세보기

21. Gianani ICA512 autoantibody radioassay Diabetes 1995 10.2337/diab.44.11.1340 44 1340 

    상세보기

22. Beever Highly sensitive assays of autoantibodies to thyroglobulin and thyroid peroxidase Clin Chem 1989 10.1093/clinchem/35.9.1949 35 1949 

    상세보기

23. Bingley Incidence of insulin dependent diabetes in England: a study in the Oxford region, 1985-6 Br Med J 1989 10.1136/bmj.298.6673.558 298 558 

    상세보기

24. Ziegler Immunotherapy of Type I Diabetes. 1989 155 

25. Kostraba Incidence of insulin-dependent diabetes mellitus in Colorado Epidemiology 1992 10.1097/00001648-199205000-00008 3 232 

    상세보기

26. LaPorte Clinico-Genetic Genesis of Diabetes Mellitus. International Congress Series 597. 1982 66 

27. Barmeier Risk for developing type 1 (insulin-dependent) diabetes mellitus and the presence of islet 64K antibodies Diabetologia 1991 10.1007/BF00401518 34 727 

    상세보기

28. Riley A prospective study of the development of diabetes in relatives of patients with insulin-dependent diabetes N Engl J Med 1990 10.1056/NEJM199010253231704 323 1167 

    상세보기

29. Maclaren Perspectives in diabetes. How, when, and why to predict IDDM Diabetes 1988 10.2337/diab.37.12.1591 37 1591 

    상세보기

30. Bingley Perspectives in diabetes. Can we really predict IDDM? Diabetes 1993 10.2337/diab.42.2.213 42 213 

    상세보기

31. Maclaren Only multiple autoantibodies to islet cells (ICA), insulin, GAD65, IA-2 and IA-2β predict immune-mediated (Type 1) diabetes in relatives J Autoimmun 1999 12 279 10.1006/jaut.1999.0281 

    상세보기

32. Dorman Diabetes in America. 1995 165 

33. Laporte RE Matsushima M Chang Y-F Prevalence and incidence of insulin-dependent diabetes Diabetes in America. 1995 37 46 

34. Palosuo High antibody levels to prothrombin imply a risk of deep venous thrombosis and pulmonary embolism in middle-aged men. A nested case-control study Thromb Haemost 1997 10.1055/s-0038-1657711 78 1178 

    상세보기

35. Bingley Combined analysis of autoantibodies improves prediction of IDDM in islet cell antibody-positive relatives Diabetes 1994 10.2337/diab.43.11.1304 43 1304 

    상세보기

36. Verge Prediction of type I diabetes mellitus in first degree relatives using a combination of insulin, glutamic acid decarboxylase and ICA512bdc/IA-2 autoantibodies Diabetes 1996 10.2337/diab.45.7.926 45 926 

    상세보기

37. Pietropaolo Combined analysis of GAD65 and ICA512 (IA-2) autoantibodies in organ and non-organ specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus J Autoimmun 1998 11 1 10.1006/jaut.1997.0170 

    상세보기

38. Ziegler Autoantibody appearance and risk for development of childhood diabetes in offspring of parents with type 1 diabetes. The 2-year analysis of the German BABYDIAB study Diabetes 1999 10.2337/diabetes.48.3.460 48 460 

    상세보기

39. Wiest-Ladenburger Combined analysis and single-step detection of GAD65 and IA2 autoantibodies can replace the histochemical islet cell antibody test Diabetes 1997 10.2337/diab.46.4.565 46 565 

    상세보기

40. Kulmala Prediction of insulin-dependint diabetes mellitus in siblings of children with diabetes J Clin Invest 1998 10.1172/JCI119879 101 327 

    상세보기

41. W orld H ealth O rganization . World Health Organization 1980 

42. Zimmet Latent autoimmune diabetes mellitus in adults (LADA): the role of antibodies to glutamic acid decarboxylase in diagnosis and prediction of insulin dependency Diabet Med 1994 10.1111/j.1464-5491.1994.tb00275.x 11 299 

    상세보기

43. Rewers Diabetes in America. 1995 179 

44. Fried The cardiovascular health study: design and rationale Ann Epidemiol 1991 10.1016/1047-2797(91)90005-W 1 263 

    상세보기

45. Pietropaolo Evidence of islet cell autoimmunity in elderly patients with Type 2 diabetes mellitus Diabetes 2000 10.2337/diabetes.49.1.32 49 32 

    상세보기

46. Dupré Clinical trials of Cyclosporin in IDDM Diabetes Care 1988 11 37 

    상세보기

47. Bougneres Factors associated with early remission of Type I diabetes in children treated with cyclosporine N Engl J Med 1988 10.1056/NEJM198803173181103 318 663 

    상세보기

48. Mahan Prediction, Prevention and Genetic Counseling. 1996 257 

49. Lipton Cyclosporin therapy for prevention and cure of IDDM. Epidemiological perspective of benefits and risks Diabetes Care 1990 10.2337/diacare.13.7.776 13 776 

    상세보기

50. Pietropaolo Current Therapy in Allergy, Immunology, and Rheumatology. 1992 365 

51. Drash Is it the time to draw the curtain on immune intervention trials in newly diagnosed patients with IDDM? Diabetes Care 1995 10.2337/diacare.18.11.1499 18 1499 

    상세보기

52. Rakotoambinina Cyclosporin A does not delay insulin dependency in asymptomatic IDDM patients Diabetes Care 1995 10.2337/diacare.18.11.1487 18 1487 

    상세보기

53. Silverstein Immunosuppression with azathioprine and prednisone in recent- onset insulin-dependent diabetes mellitus N Engl J Med 1988 10.1056/NEJM198809083191002 319 599 

    상세보기

54. Harrison Increase in remission rate in newly diagnosed type I diabetic subjects treated with azathioprine Diabetes 1985 10.2337/diab.34.12.1306 34 1306 

    상세보기

55. Pozzilli The potential role of nicotinamide in the secondary prevention of IDDM Diabetes Nutr Metab 1993 9 219 

56. Elliott A population based strategy to prevent insulin-dependent diabetes using nicotinamide J Pediatr Endocrinol Metab 1996 10.1515/JPEM.1996.9.5.501 9 501 

    상세보기

57. Lampeter The Deutsche Nicotinamide Intervention Study: An attempt to prevent Type 1 diabetes. DENIS Group Diabetes 1998 10.2337/diabetes.47.6.980 47 980 

    상세보기

58. DPT- The Diabetes Prevention Trial-type 1diabetes (DPT-1): implementation of screening and staging of relatives Transplant Proc 1995 27 337 

59. Levy-Marchal Multiple beta cells antibodies are not associated with high risk HLA genotypes in schoolchildren from the general population Diabetes 1997 46 Suppl.1 198A 

60. Pietropaolo Are GAD65 and IA-2 autoantibodies sufficient to predict Type 1 diabetes? Diabetes 1999 48 Suppl.1 A45 

61. Cornell Absence of islet autoantibodies at diabetes onset does not rule out Type 1A diabetes Diabetes 2000 49 Suppl.1 A68 

62. Roep T-cell responses to autoantigens in IDDM. The search for the holy grail Diabetes 1996 10.2337/diab.45.9.1147 45 1147 

    상세보기

63. Brooks-Worrell Cellular immune responses to human islet proteins in antibody-positive type 2 diabetic patients Diabetes 1999 10.2337/diabetes.48.5.983 48 983 

    상세보기

64. Dosch Persistent T cell anergy in human type 1 diabetes J Immunol 1999 10.4049/jimmunol.163.12.6933 163 6933 

    상세보기

65. Sabbah Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset Type 1 diabetes Diabetes Care 2000 10.2337/diacare.23.9.1326 23 1326 

    상세보기

66. The Diabetes Control and Complication Trial Research Group. Effect of intensive therapy on residual β-cell function in patients with Type 1 diabetes in the Diabetes Control and Complication Trial. A randomized, controlled trial Ann Int Med 1998 10.7326/0003-4819-128-7-199804010-00001 128 517 

    상세보기

67. Greenbaum Relationship of β-cell function and autoantibodies to progression and nonprogression of subclinical Type 1 diabetes. Follow-up of the Seattle family study Diabetes 1999 10.2337/diabetes.48.1.170 48 170 

    상세보기

68. Jackson Dual parameter linear model for prediction of onset of type I diabetes in islet cell antibody positive relatives Clin Res 1988 36 585A 

69. McCulloch The appropriate use of B-cell function testing in the preclinical period of type I diabetes Diabetic Med 1991 10.1111/j.1464-5491.1991.tb02116.x 8 800 

    상세보기

70. McCulloch Comparison of bolus and infusion protocols for determining acute insulin response to intravenous glucose in normal humans. The ICARUS Group. Islet Cell Antibody Register User's Study Diabetes Care 1993 10.2337/diacare.16.6.911 16 911 

    상세보기

71. Eisenbarth Dual-parameter model for prediction of type I diabetes mellitus Proc Ass Am Phys 1998 110 126 

72. Shah A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus N Engl J Med 1989 10.1056/NEJM198903023200902 320 550 

    상세보기

73. Wahren Does C-peptide has a physiological role? Diabetologia 1994 10.1007/BF00400832 37 Suppl.2 S99 

    상세보기

74. Steiner Proinsulin C-peptide-biological activity? Science 1997 277 531 10.1126/science.277.5325.531 

    상세보기

75. Ohtomo Differential effects of proinsulin C-peptide fragments on Na+, K+-ATPase activity in synergism with neuropeptide Y Diabetologia 1998 41 287 10.1007/s001250050905 

    상세보기

76. Gunaratnam Precipitation of IDDM by the ICA69 T cell epitope peptide, Tep69 Diabetes 1998 47 Suppl.1 A34 

77. Simone Immunologic ‘vaccination’ for the prevention of autoimmune diabetes (Type 1A) Diabetes Care 1999 22 B7 

78. Chatenaud CD3 antibody-induced dominant self tolerance on overtly diabetic NOD mice J Immunol 1997 10.4049/jimmunol.158.6.2947 158 2947 

    상세보기